RT Journal
A1 Banerjee D, Stafford RS
T1 LAck of improvement in outpatient management of congestive heart failure in the united states
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2010
FD August 9
VO 170
IS 15
SP 1399
OP 1400
DO 10.1001/archinternmed.2010.270
UL http://dx.doi.org/10.1001/archinternmed.2010.270
AB 
Congestive heart failure (CHF) accounts for 3% of admissions to US hospitals, and the diagnosis carries a mortality rate of 20% at 1 year and 80% at 8 years.1- 2 Numerous advances in the chronic medical management of CHF, including angiotensin antagonists, β-blockers, and aldosterone antagonists, have significantly reduced mortality in clinical trial populations with varying degrees of CHF severity.2- 4 Practices proven in clinical trials, however, do not always readily translate to community practice.5- 6 Previous studies in outpatient populations in the late 1990s through the early 2000s observed suboptimal adoption of evidence-based therapy for CHF. Using nationally representative data, we evaluated whether patterns of medication use have improved.